BioSpace News Archive

G100 is a product candidate from Immune Design’s GLAAS discovery platform.

Grandomics acquired the first Saphyr earlier this year as they begin to build a large capacity for generating Bionano data.

ThromboGenics issues a business update for the three-month period ending 30 September 2017.

RenovaCare announced that it has entered into definitive agreements with investors to purchase an aggregate of approximately 915,000 shares of common stock in a registered direct offering and common stock purchase warrants in a concurrent private placement.

Vector Laboratories a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today the availability of a new guide for the growing field of immunofluorescence (IF).

CPhI Worldwidee - held in Frankfurt, October 24-26 and organised by UBM - announces the findings of part ii of the 5th edition of the CPhI Annual Report, which focuses on the immediate and long-term trends in pharmaceutical manufacturing and ingredients.

STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their integrated API process R&D and manufacturing site in Changzhou China.

Inspired by a color changing mechanism found in cephalopods, like squid, cuttlefish and octopus, researchers at the University of New Hampshire have conceived a design for a unique sequential cell-opening mechanism that has many potential applications from drug delivery to color altering camouflage materials.

CancerCell a startup incubating within the Leonhardt’s Launchpads innovation accelerator labs in California and Utah has announced it has filed new provisional patent application claims for bioelectric cancer tumor treatment.

For years, chiropractors have used chiropractic manipulation to create positive effects for many patients.